Atea Pharmaceuticals, Inc.
AVIR
Revenue
192.18M
▲159.37M▲485.72%
3 Months ChangeAssets
464.67M
▼-26.29M▼-5.35%
3 Months ChangeLiabilities
25.80M
▼-6.64M▼-20.46%
3 Months ChangeFree Cash Flow
-59.05M
▼-59.05M-∞%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-07
Form 10-Q
ID: 0000950170-24-092914
2024-08-07
Form 8-K
ID: 0001193125-24-195895
2024-06-21
Form 8-K
ID: 0001193125-24-165886
2024-05-14
Form 10-Q
ID: 0000950170-24-059699
2024-05-14
Form 8-K
ID: 0001193125-24-138249
2024-02-28
Form 8-K
ID: 0001193125-24-050724
2023-11-08
Form 10-Q
ID: 0000950170-23-061213
2023-11-08
Form 8-K
ID: 0001193125-23-273532
2023-08-08
Form 10-Q
ID: 0000950170-23-039920
2023-08-08
Form 8-K
ID: 0001193125-23-206247